This Solicitation opportunity from Government of Canada was posted on January 23, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

RFP PHSA 16956 Provincial Retinal Diseases Treatment Program (PRDTP) Pharmacy Services

Closed

BC224141International

Submission Closed03/06/2026, 10:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412

New

DIBBS

Supply of Combined SPF 30 Sunscreen and All-Natural Insect Repellent

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Coronavirus Detection Test Kit Supply

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Supply of Disposable PVP Iodine Swab Sticks

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Supply of Omeprazole Extended-Release Capsules

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Famotidine Tablets (20 MG)

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Zinc Oxide Ointment Manufacturer

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

OEM Manufacturer of Alcohol-Based Hand Sanitizer

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

NSN 6550-01-2215400 Material Supplier

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Solicitation # SPE2DP-27-T-0284

Solicitation SPE2DP-27-T-0284 is for the procurement of Zinc Oxide Ointment (NSN 6505001501990), a topical skin protectant containing 20% zinc oxide. The product must meet USP standards and be supplied in collapsible tubes, with each unit of issue consisting of a 28.35gm (1oz) tube. The procurement is divided into multiple line items, including CLIN 0001 for 6 units, CLIN 0002 for 4 units, and CLIN 0004 for 5 units. The ointment must be stored at a controlled room temperature not exceeding 30°C (86°F) and has a non-extendable shelf life of 36 months. The contract requires delivery FOB Destination to the Naval Medical Readiness Logistics Command in Williamsburg, Virginia, with a delivery window of 5 days and required delivery dates in November 2026. Packaging must adhere to DLA requirements, with hazardous materials following TQ requirement IP025 and non-hazardous materials following ASTM D3951. All shipments must be sent via the fastest traceable means, as parcel post is prohibited. The contract incorporates various FAR and DFARS clauses, including requirements for cybersecurity reporting, the Buy American Act, and FDA regulation compliance. Invoicing and payment must be processed electronically through the Wide Area WorkFlow (WAWF) system.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-27-T-0273

Solicitation SPE2DP-27-T-0273 is a fixed-price, small business set-aside procurement for Famotidine Tablets, 20 MG, in unit dose 100s. The requirement is for four packages, with each package containing 100 tablets, under NSN 6505013104178. This FDA-regulated drug must be delivered FOB Destination to the Medical Company in Worcester, Massachusetts, with a required delivery date of November 12, 2026, and a delivery lead time of five days. Inspection and acceptance will occur at the destination per FAR 52.246-2. The contractor must adhere to strict packaging and marking standards, utilizing commercial packaging and ensuring each unit is in a sealed container to prevent damage. All materials must be marked according to Medical Marking Standard No. 1, which supersedes MIL-STD-129. The item is subject to a non-extendable shelf-life requirement of 30 months. Administrative requirements include the use of the Wide Area WorkFlow system for invoicing and payment, compliance with the Buy American and Balance of Payments Program, and adherence to DFARS cybersecurity and hazardous material labeling regulations.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

TEST STRIPS AND COLOR

Solicitation # SPE2DS-27-T-1624

Solicitation SPE2DS-27-T-1624 is for the procurement of medical test strips and color charts (NSN 6550-01-221-5400) used to analyze bilirubin, blood, glucose, ketones, leukocytes, nitrite, pH, protein, specific gravity, and urobilinogen in urine. The requirement consists of three line items, each for one bottle containing 100 strips. Delivery is required within 20 days after order, with destination points at Fort Campbell, Kentucky, and the USNS Charles Drew. The items are subject to a non-extendable shelf life of 18 months, with a requirement that no more than two months elapse between the date of manufacture and the date of delivery to the government. Packaging must be commercial and compliant with ASTM D3951 and MIL-STD-2073-1E, while marking must adhere to Medical Marking Standard No. 1. The contract incorporates several critical regulatory clauses, including the Buy American Act, the Berry Amendment, and DFARS 252.204-7012 regarding the safeguarding of covered defense information. Payment and receiving reports must be processed electronically via the Wide Area WorkFlow system. Inspection and acceptance will occur at the destination.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

OMEPRAZOLE EXTENDED-RE

Solicitation # SPE2DP-27-T-0286

Solicitation SPE2DP-27-T-0286 is a procurement for Omeprazole Extended-Release Capsules, 20 mg, in quantities of 30 per unit. The contract consists of two line items, each for 4 bottles, with a required delivery date of November 13, 2026. The items must be stored at USP controlled room temperature between 20 and 25 degrees Celsius and have a non-extendable shelf life of 18 months. Delivery is FOB Destination, with inspection and acceptance occurring at the destination points in Worcester, Massachusetts, and Fort Lewis, Washington. Packaging must be commercial and compliant with ASTM D3951 for non-hazardous materials or TQ requirement IP025 for hazardous materials. All items must be marked according to Medical Marking Standard No. 1, which supersedes MIL-STD-129. The contract incorporates various FAR and DFARS clauses, including requirements for destination inspection, safeguarding covered defense information, and the use of the Wide Area Workflow system for electronic invoicing. All quotes must be submitted via the DLA Internet Bid Board System.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

37 minutes ago

DEADLINE

in 6 days

AI Contract Overview

The Provincial Health Services Authority (PHSA) has issued a Request for Proposals (RFP) to secure a supplier or multiple suppliers for single-use intravitreal prefilled syringes containing anti-vascular endothelial growth factor (anti-VEGF) drugs. These syringes are intended for ophthalmic treatments provided through the Provincial Retinal Diseases Treatment Program (PRDTP), a PHSA initiative. The contract is non-exclusive, allowing for multiple proponents to be selected, and covers supply to specific program clinics outlined in the RFP documentation. Interested proponents must respond by the deadline of March 6, 2026. The procurement is managed by PHSA, operating under the Government of Canada, and communication is conducted through the designated Contracting Authority via email. The RFP aims to support the delivery of specialized retinal disease treatments by ensuring a reliable supply of necessary pharmaceutical products to PRDTP clinics.

General Info

PHSA seeks suppliers for anti-VEGF prefilled syringes for retinal treatments; proposals due March 6, 2026.

Agency

Government of Canada → Provincial Health Services Authority (Incl. BCCSS)

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

CAN

Set-Aside

NONE

Documents

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseClosed

PostedJan 23

Solicitation

Response DeadlineMar 6

Deadline has passed

Submission Closed

03/06/2026, 10:00:00 PM UTC

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyGovernment of Canada → Provincial Health Services Authority (Incl. BCCSS)

Contacts1 person available

OfficeN/A

Organization / AgencyGovernment of Canada → Provincial Health Services Authority (Incl. BCCSS)

Office AddressN/A

Contacts

Contracting Authority

Full Description

This RFP is being issued by Provincial Health Services Authority (“PHSA”) to identify a Proponent or Proponent(s) to enter into a non-exclusive Contract between the Proponent(s) and the PHSA, for the supply of single-use intravitreal prefilled syringes containing anti-vascular endothelial growth factor (anti-VEGF) drugs for use in ophthalmic treatments described herein, to the Provincial Retinal Diseases Treatment Program (“PRDTP”) (a program of PHSA) at their program clinics listed in Appendix G (List Of Participating PRDTP Clinics).